These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23871799)

  • 1. Technologic developments in the field of photonics for the detection of urinary bladder cancer.
    Palmer S; Sokolovski SG; Rafailov E; Nabi G
    Clin Genitourin Cancer; 2013 Dec; 11(4):390-6. PubMed ID: 23871799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary biomarkers of bladder cancer: an update and future perspectives.
    Rosser CJ; Urquidi V; Goodison S
    Biomark Med; 2013 Oct; 7(5):779-90. PubMed ID: 24044570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive urine based tests for the detection of bladder cancer.
    Wadhwa N; Jatawa SK; Tiwari A
    J Clin Pathol; 2012 Nov; 65(11):970-5. PubMed ID: 22685259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Telomerase activity: a molecular marker for early diagnosis of bladder tumor].
    Calistri D; Sanchini A; Amadori D; Silvestrini R
    Recenti Prog Med; 2007 Feb; 98(2):74-8. PubMed ID: 17439065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.
    Curigliano G; Ferretti G; Flamini G; Goldhirsch A; de Braud F; Calabro MG; Mandaly M; Nole F; De Pas T; D'Addessi A; Cittadini A
    Anticancer Res; 2001; 21(4B):3015-20. PubMed ID: 11712804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?
    Gazquez C; Ribal MJ; Marín-Aguilera M; Kayed H; Fernández PL; Mengual L; Alcaraz A
    BJU Int; 2012 Nov; 110(9):1310-6. PubMed ID: 22416928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers?
    Gakis G; Kruck S; Stenzl A
    Curr Opin Urol; 2010 Sep; 20(5):388-92. PubMed ID: 20657287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
    Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
    Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006.
    Engholm G; Hakulinen T; Gislum M; Tryggvadóttir L; Klint A; Bray F; Storm HH
    Acta Oncol; 2010 Jun; 49(5):655-64. PubMed ID: 20156116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary markers in the detection of bladder cancer: what's new?
    Nielsen ME; Schaeffer EM; Veltri RW; Schoenberg MP; Getzenberg RH
    Curr Opin Urol; 2006 Sep; 16(5):350-5. PubMed ID: 16905981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
    Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of cytology, nuclear matrix protein 22 (NMP22) test, and urinary bladder cancer II (UBC II) test in early recurrent transitional cell carcinoma of the bladder.
    Kibar Y; Goktas S; Kilic S; Yaman H; Onguru O; Peker AF
    Ann Clin Lab Sci; 2006; 36(1):31-8. PubMed ID: 16501234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer.
    Dettlaff-Pokora A; Matuszewski M; Schlichtholz B
    Cancer Lett; 2005 May; 222(1):83-8. PubMed ID: 15837544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.